Does METRELEPTIN Cause Injection site extravasation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site extravasation have been filed in association with METRELEPTIN (Myalept). This represents 0.4% of all adverse event reports for METRELEPTIN.
5
Reports of Injection site extravasation with METRELEPTIN
0.4%
of all METRELEPTIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site extravasation From METRELEPTIN?
Of the 5 reports.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METRELEPTIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does METRELEPTIN Cause?
Therapy cessation (94)
Product dose omission issue (88)
Weight decreased (88)
Blood glucose increased (77)
Drug ineffective (69)
Therapy interrupted (65)
Nausea (57)
Off label use (51)
Blood triglycerides increased (49)
Treatment noncompliance (49)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which METRELEPTIN Alternatives Have Lower Injection site extravasation Risk?
METRELEPTIN vs METRONIDAZOLE
METRELEPTIN vs METRONIDAZOLE\METRONIDAZOLE
METRELEPTIN vs METYRAPONE
METRELEPTIN vs MEXILETINE
METRELEPTIN vs MIANSERIN